Methylation biomarkers for pleomorphic lobular breast cancer - a short report

Cathy B. Moelans, Eva J. Vlug, Cigdem Ercan, Peter Bult, Horst Buerger, Gabor Cserni, Paul J. van Diest, Patrick W.B. Derksen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Pleomorphic invasive lobular cancer (pleomorphic ILC) is a rare variant of ILC that is characterized by a classic ILC-like growth pattern combined with an infiltrative ductal cancer (IDC)-like high nuclear atypicality. There is an ongoing discussion whether pleomorphic ILC is a dedifferentiated form of ILC or in origin an IDC with a secondary loss of cohesion. Since gene promoter hypermethylation is an early event in breast carcinogenesis and thus may provide information on tumor progression, we set out to compare the methylation patterns of pleomorphic ILC, classic ILC and IDC. In addition, we aimed at analyzing the methylation status of pleomorphic ILC. Methods: We performed promoter methylation profiling of 24 established and putative tumor suppressor genes by methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) analysis in 20 classical ILC, 16 pleomorphic ILC and 20 IDC cases. Results: We found that pleomorphic ILC showed relatively low TP73 and MLH1 methylation levels and relatively high RASSF1A methylation levels compared to classic ILC. Compared to IDC, pleomorphic ILC showed relatively low MLH1 and BRCA1 methylation levels. Hierarchical cluster analysis revealed a similar methylation pattern for pleomorphic ILC and IDC, while the methylation pattern of classic ILC was different. Conclusion: This is the first report to identify TP73, RASSF1A, MLH1 and BRCA1 as possible biomarkers to distinguish pleomorphic ILC from classic ILC and IDC.

Original languageEnglish
Pages (from-to)397-405
Number of pages9
JournalCellular Oncology
Volume38
Issue number5
DOIs
Publication statusPublished - Oct 1 2015

    Fingerprint

Keywords

  • DNA hypermethylation
  • Epigenetics
  • Lobular breast cancer
  • MS-MLPA
  • Pleomorphic lobular breast cancer
  • Sporadic breast cancer

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research

Cite this

Moelans, C. B., Vlug, E. J., Ercan, C., Bult, P., Buerger, H., Cserni, G., van Diest, P. J., & Derksen, P. W. B. (2015). Methylation biomarkers for pleomorphic lobular breast cancer - a short report. Cellular Oncology, 38(5), 397-405. https://doi.org/10.1007/s13402-015-0241-9